Protect science funding and modernize clinical trials
Auchincloss supports defending the integrity of the National Institutes of Health and the Food and Drug Administration. He says science funding should be decided by peer review rather than politics and that medicines should be evaluated on safety and effectiveness. He is also leading legislation to modernize U.S. clinical-trial infrastructure, which he says could speed trials and drug development.
Context: The passage does not specify the changes proposed for clinical-trial infrastructure.